Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men

Anne Rositch, Michael G. Hudgens, Danielle M. Backes, Stephen Moses, Kawango Agot, Edith Nyagaya, Peter J F Snijders, Chris J L M Meijer, Robert C. Bailey, Jennifer S. Smith

Research output: Contribution to journalArticle

Abstract

Background.Little is known about type-specific associations between prevalent human papillomavirus (HPV) infections and risk of acquiring other HPV types in men. Data on natural clustering of HPV types are needed as a prevaccine distribution to which postvaccine data can be compared.Methods.Using data from a randomized controlled trial of male circumcision in Kisumu, Kenya, adjusted mean survival ratios were estimated for acquisition of any-HPV, high-risk (HR) HPV, and individual HR-HPV types among men uninfected as compared to those infected with vaccine-relevant HPV types 16, 18, 31, 45, 6, or 11 at baseline.Results.Among 1097 human immunodeficiency virus-negative, uncircumcised men, 2303 incident HPV infections were detected over 2534 person-years of follow-up. Although acquisition of individual HR-HPV types varied by baseline HPV type, there was no clear evidence of shorter times to acquisition among men without vaccine-relevant HPV-16, -18, -31, -45, -6, or -11 infections at baseline, as compared to men who did have these infections at baseline.Conclusions.These prospective data on combinations of HPV infections over time do not suggest the potential for postvaccination HPV type replacement. Future surveillance studies are needed to definitely determine whether elimination of HPV types by vaccination will alter the HPV type distribution in the population.

Original languageEnglish (US)
Pages (from-to)669-677
Number of pages9
JournalJournal of Infectious Diseases
Volume206
Issue number5
DOIs
StatePublished - Sep 1 2012

Fingerprint

Papillomavirus Infections
Vaccines
Human papillomavirus 18
Human papillomavirus 16
Male Circumcision
Kenya
Infection
Cluster Analysis
Vaccination
Randomized Controlled Trials

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men. / Rositch, Anne; Hudgens, Michael G.; Backes, Danielle M.; Moses, Stephen; Agot, Kawango; Nyagaya, Edith; Snijders, Peter J F; Meijer, Chris J L M; Bailey, Robert C.; Smith, Jennifer S.

In: Journal of Infectious Diseases, Vol. 206, No. 5, 01.09.2012, p. 669-677.

Research output: Contribution to journalArticle

Rositch, A, Hudgens, MG, Backes, DM, Moses, S, Agot, K, Nyagaya, E, Snijders, PJF, Meijer, CJLM, Bailey, RC & Smith, JS 2012, 'Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men', Journal of Infectious Diseases, vol. 206, no. 5, pp. 669-677. https://doi.org/10.1093/infdis/jis406
Rositch, Anne ; Hudgens, Michael G. ; Backes, Danielle M. ; Moses, Stephen ; Agot, Kawango ; Nyagaya, Edith ; Snijders, Peter J F ; Meijer, Chris J L M ; Bailey, Robert C. ; Smith, Jennifer S. / Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men. In: Journal of Infectious Diseases. 2012 ; Vol. 206, No. 5. pp. 669-677.
@article{879e5e9a185c42f4a0a8c1b2a8bbbb37,
title = "Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men",
abstract = "Background.Little is known about type-specific associations between prevalent human papillomavirus (HPV) infections and risk of acquiring other HPV types in men. Data on natural clustering of HPV types are needed as a prevaccine distribution to which postvaccine data can be compared.Methods.Using data from a randomized controlled trial of male circumcision in Kisumu, Kenya, adjusted mean survival ratios were estimated for acquisition of any-HPV, high-risk (HR) HPV, and individual HR-HPV types among men uninfected as compared to those infected with vaccine-relevant HPV types 16, 18, 31, 45, 6, or 11 at baseline.Results.Among 1097 human immunodeficiency virus-negative, uncircumcised men, 2303 incident HPV infections were detected over 2534 person-years of follow-up. Although acquisition of individual HR-HPV types varied by baseline HPV type, there was no clear evidence of shorter times to acquisition among men without vaccine-relevant HPV-16, -18, -31, -45, -6, or -11 infections at baseline, as compared to men who did have these infections at baseline.Conclusions.These prospective data on combinations of HPV infections over time do not suggest the potential for postvaccination HPV type replacement. Future surveillance studies are needed to definitely determine whether elimination of HPV types by vaccination will alter the HPV type distribution in the population.",
author = "Anne Rositch and Hudgens, {Michael G.} and Backes, {Danielle M.} and Stephen Moses and Kawango Agot and Edith Nyagaya and Snijders, {Peter J F} and Meijer, {Chris J L M} and Bailey, {Robert C.} and Smith, {Jennifer S.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1093/infdis/jis406",
language = "English (US)",
volume = "206",
pages = "669--677",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men

AU - Rositch, Anne

AU - Hudgens, Michael G.

AU - Backes, Danielle M.

AU - Moses, Stephen

AU - Agot, Kawango

AU - Nyagaya, Edith

AU - Snijders, Peter J F

AU - Meijer, Chris J L M

AU - Bailey, Robert C.

AU - Smith, Jennifer S.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background.Little is known about type-specific associations between prevalent human papillomavirus (HPV) infections and risk of acquiring other HPV types in men. Data on natural clustering of HPV types are needed as a prevaccine distribution to which postvaccine data can be compared.Methods.Using data from a randomized controlled trial of male circumcision in Kisumu, Kenya, adjusted mean survival ratios were estimated for acquisition of any-HPV, high-risk (HR) HPV, and individual HR-HPV types among men uninfected as compared to those infected with vaccine-relevant HPV types 16, 18, 31, 45, 6, or 11 at baseline.Results.Among 1097 human immunodeficiency virus-negative, uncircumcised men, 2303 incident HPV infections were detected over 2534 person-years of follow-up. Although acquisition of individual HR-HPV types varied by baseline HPV type, there was no clear evidence of shorter times to acquisition among men without vaccine-relevant HPV-16, -18, -31, -45, -6, or -11 infections at baseline, as compared to men who did have these infections at baseline.Conclusions.These prospective data on combinations of HPV infections over time do not suggest the potential for postvaccination HPV type replacement. Future surveillance studies are needed to definitely determine whether elimination of HPV types by vaccination will alter the HPV type distribution in the population.

AB - Background.Little is known about type-specific associations between prevalent human papillomavirus (HPV) infections and risk of acquiring other HPV types in men. Data on natural clustering of HPV types are needed as a prevaccine distribution to which postvaccine data can be compared.Methods.Using data from a randomized controlled trial of male circumcision in Kisumu, Kenya, adjusted mean survival ratios were estimated for acquisition of any-HPV, high-risk (HR) HPV, and individual HR-HPV types among men uninfected as compared to those infected with vaccine-relevant HPV types 16, 18, 31, 45, 6, or 11 at baseline.Results.Among 1097 human immunodeficiency virus-negative, uncircumcised men, 2303 incident HPV infections were detected over 2534 person-years of follow-up. Although acquisition of individual HR-HPV types varied by baseline HPV type, there was no clear evidence of shorter times to acquisition among men without vaccine-relevant HPV-16, -18, -31, -45, -6, or -11 infections at baseline, as compared to men who did have these infections at baseline.Conclusions.These prospective data on combinations of HPV infections over time do not suggest the potential for postvaccination HPV type replacement. Future surveillance studies are needed to definitely determine whether elimination of HPV types by vaccination will alter the HPV type distribution in the population.

UR - http://www.scopus.com/inward/record.url?scp=84864946551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864946551&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis406

DO - 10.1093/infdis/jis406

M3 - Article

C2 - 22711906

AN - SCOPUS:84864946551

VL - 206

SP - 669

EP - 677

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -